Form 4: Medtronic Director Lidia Fonseca Reports Stock Transactions
SEC Form 4
Director Lidia Fonseca reported the acquisition of 2,165 ordinary shares and disposal of 55 shares of Medtronic plc.
Summary
- On April 29, 2024, Lidia Fonseca, a director of Medtronic plc, acquired 2,165 ordinary shares at a price of $80.86 per share.
- These shares were awarded as restricted stock units, vesting one year from the award date.
- Fonseca also disposed of 55 shares through dividend reinvestment since the last report.
- Following these transactions, Fonseca beneficially owns 3,844 shares of Medtronic plc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard SEC filing reporting stock transactions.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the healthcare industry.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how investors interpret insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 04/29/2024 | Date of transaction: Acquisition of shares and disposal of shares. |
| 05/01/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.